Skip to content
value.today

Johnson & Johnson vs Nirvana Life Sciences Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Johnson & Johnson is the larger company by market value: $652.5 B against $4 M for Nirvana Life Sciences Inc., 163119 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Dec 25, 2022 for Nirvana Life Sciences Inc.). Nirvana Life Sciences Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.

Market cap history

$0 M$176.2 B$352.3 B$528.5 B$704.7 B2020202120222023202420252026
● Johnson & Johnson● Nirvana Life Sciences Inc.

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$24B$47B$71B$94B20182019202020212022202320242025Johnson & Johnson $94B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureJohnson & Johnson
JNJ · #23 in the world
Nirvana Life Sciences Inc.
NIRV.CN
Profile
Country🇺🇸 USA🇨🇦 Canada
SectorHealthcareHealthcare
IndustryPharmaceutical—
Founded1886—
Size
Market cap$652.5 B$4 M*
Revenue$94.2 B—
Net income$26.8 B—
Employees138,200—
Valuation
P/E ratio40.5×—
Price to sales6.6×—
Price to book8.0×—
Free cash flow yield3.0%—
Altman Z-score zone——
Data as ofMarket cap Oct 2026Market cap Dec 2022

Questions and answers#

Which is bigger, Johnson & Johnson or Nirvana Life Sciences Inc.?

Johnson & Johnson is the larger company by market value: $652.5 B against $4 M for Nirvana Life Sciences Inc., 163119 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Dec 25, 2022 for Nirvana Life Sciences Inc.). Nirvana Life Sciences Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.